On June 1, 2021, John J. Moroney announced that he intends to have conversations or communications with American Bio Medica Corporation’s management, members of its board of directors and other shareholders to discuss John J. Moroney’s thoughts and ideas. John J. Moroney expressed his views that the Company’s shareholders would be better served if the Company: (a) reduces Melissa A. Waterhouse’s duties to a more manageable level by supplementing management with a more experienced executive, (b) replaces Melissa A. Waterhouse with an individual to serve as the Company’s Chief Financial Officer, (c) increases the size of the Company’s board of directors and fill such positions with industry experienced individuals who hopefully will own or acquire shares of Company’s common stock and have interests better aligned with the Company’s shareholders and (d) secures additional, long term capital in order to provide the Company with a better opportunity for long term growth.